For COVID-19 clinical trials, we advise researchers to give careful thought to trials’ inclusion and exclusion criteria, make sure people are aware of and invited to participate in trials when eligible, ensure that those eligible to participate have access to studies where they live or get their care, and minimize participation burden. This piece first appeared in Health Affairs and has been cross-posted with permission. Read more
24Jun2020
Cross-Post: Clinical Trials For COVID-19 – Populations Most Vulnerable To COVID-19 Must Be Included
Tags:
24 Jun
No comments